Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Plaintiffs’ attorneys Andy Birchfield and Dan Robinson told a Los Angeles Superior Court jury on Thursday about their clients, two women in California who got ovarian cancer after decades of using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback